Quality Excellence Award

Entries should demonstrate an exceptional commitment to pharmaceutical quality, GMP compliance and the development of a strong quality culture. Judges will consider quality systems, risk management, inspection readiness, deviation and CAPA management, batch reliability and continuous improvement. Submissions should outline the approach taken and provide measurable evidence of impact. Relevant evidence may include KPIs, audit or inspection outcomes, training initiatives, reductions in recurring issues or other measures demonstrating employee ownership, sustained compliance and improved quality performance.

Judging criteria

GMP compliance, audit outcomes, quality systems, CAPA management and measurable improvements